Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
18
% (year-on-year change in business profit)Wording
Avoiding a definitive answer
How definitive the wording is.Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedIFRSNet Sales1,851,563¥ millionYear on year +5.4%Progress 74.7%
Operating profit197,264¥ millionYear on year +36.2%Progress 85.8%
Ordinary income224,861¥ millionYear on year +34.4%Progress 86.8%
Net income attributable to owners of the parent147,391¥ millionYear on year +43.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥183.91
Financial position at period-end
Total assets3,331,804¥ million
of which net assets 1,650,807 ¥ millionEquity ratio 40.1%vs. prior year-end +3.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+194,741
Investment+24,484
Financials-222,677
Net change-3,452
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥129,096 million
Segment revenueAlcoholic Beverages ¥797,490 million (YoY +3.7%), Beverages ¥456,245 million (YoY +6.2%), Pharmaceuticals ¥384,807 million (YoY +10.2%), Health Science ¥193,484 million (YoY +3.0%)
Segment profitAlcoholic Beverages ¥95,629 million (YoY +5.2%), Beverages ¥51,769 million (YoY -1.7%), Pharmaceuticals ¥88,067 million (YoY +44.2%), Health Science ¥17,030 million (YoY +34.4%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥2,480,000 million (YoY +1.9%)
Business profit¥253,000 million (YoY +0.5%)
Operating profit¥230,000 million (YoY +9.7%)
Ordinary income¥259,000 million (YoY +8.9%)
Profit for the period¥194,000 million (YoY +8.9%)
Profit attributable to owners of the parent¥160,000 million (YoY +8.4%)
Annual Dividend Forecast¥74 → ¥76（+2.7%）
Factors Behind Changes in Business Performance
The factors behind the overall change in performance are not explained in the main text. A gain on transfer of ¥29,033 million associated with the loss of control of Four Roses was recorded in other operating income.
Disclosure regarding the going concern assumption
No applicable matters. The filing states, “There are no applicable matters.”
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 Not disclosed
Changes in the scope of consolidationNew 0 / Excluded 1 / Company name Four Roses Distillery, LLC
Material subsequent eventsOn 7 October 2026, consolidated subsidiary Kirin Brewery was searched by the Japan Fair Trade Commission on suspicion of violating the Antimonopoly Act. At this time, it is difficult to reasonably estimate the impact on the consolidated financial statements.
Impairment loss¥10,264 million
Breakdown of extraordinary income (loss)Description Not disclosed / Individual performance items Item Gain on transfer associated with the loss of control of Four Roses / Amount ¥29,033 million, Item Impairment Losses / Amount ¥10,264 million
Depreciation and amortization¥81,321 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Institutional investors and securities analysts
Issued Shares at Period-End816,000,000
Treasury Shares at Period-End25,463,544
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥1,851,563 million (YoY +5.4%) |
| Operating profit | ¥197,264 million (YoY +36.2%) |
| Ordinary income | ¥224,861 million (YoY +34.4%) |
| Profit attributable to owners of the parent | ¥147,391 million (YoY +43.3%) |
| Net income per share | ¥183.91 |
| Equity ratio | End of the current fiscal period 40.1 / End of previous period 36.8 |
| Total assets | ¥3,331,804 million |
| Net assets | ¥1,650,807 million |
| Cash flows from operating activities | ¥194,741 million |
| Cash flows from investing activities | ¥24,484 million |
| Cash flows from financing activities | ¥-222,677 million |
| Cash and cash equivalents at end of period | ¥129,096 million |
| Full-year earnings forecast | Net Sales ¥2,480,000 million (YoY +1.9%) / Business profit ¥253,000 million (YoY +0.5%) / Operating profit ¥230,000 million (YoY +9.7%) / Ordinary income ¥259,000 million (YoY +8.9%) / Profit for the period ¥194,000 million (YoY +8.9%) / Profit attributable to owners of the parent ¥160,000 million (YoY +8.4%) |
| Annual Dividend Forecast | ¥74 → ¥76（+2.7%） |
| Segment revenue | Alcoholic Beverages ¥797,490 million (YoY +3.7%), Beverages ¥456,245 million (YoY +6.2%), Pharmaceuticals ¥384,807 million (YoY +10.2%), Health Science ¥193,484 million (YoY +3.0%) |
| Segment profit | Alcoholic Beverages ¥95,629 million (YoY +5.2%), Beverages ¥51,769 million (YoY -1.7%), Pharmaceuticals ¥88,067 million (YoY +44.2%), Health Science ¥17,030 million (YoY +34.4%) |
| Depreciation and amortization | ¥81,321 million |
| Impairment loss | ¥10,264 million |
| Breakdown of extraordinary income (loss) | Description Not disclosed / Individual performance items Item Gain on transfer associated with the loss of control of Four Roses / Amount ¥29,033 million, Item Impairment Losses / Amount ¥10,264 million |
| Disclosure regarding the going concern assumption | No applicable matters. The filing states, “There are no applicable matters.” |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New 0 / Excluded 1 / Company name Four Roses Distillery, LLC |
| Material subsequent events | On 7 October 2026, consolidated subsidiary Kirin Brewery was searched by the Japan Fair Trade Commission on suspicion of violating the Antimonopoly Act. At this time, it is difficult to reasonably estimate the impact on the consolidated financial statements. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and securities analysts |
| Issued Shares at Period-End | 816,000,000 |
| Treasury Shares at Period-End | 25,463,544 |
| Factors Behind Changes in Business Performance | The factors behind the overall change in performance are not explained in the main text. A gain on transfer of ¥29,033 million associated with the loss of control of Four Roses was recorded in other operating income. |
Items this document does not state (6)
Operating MarginRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reasons for the overall change in performance are not explained in the main text. It states that a gain on transfer of ¥29,033 million associated with the loss of control of Four Roses Distillery, LLC was recorded in other operating income.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.